Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its unique precision neuroscience approach combining target specificity, patient selection, drug design and optimization, and novel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders. Currently in early clinical development, Cadent is rapidly advancing its pipeline of therapies to treat spinocerebellar ataxia, essential tremor and schizophrenia. Investors include Atlas Venture, Clal Biotechnology Industries, Slater Technology Fund. Cowen, Qiming Venture Partners, Access Industries, and Novartis. For more information, please visit cadenttx.com.
View Top Employees from Cadent TherapeuticsWebsite | http://www.cadenttx.com |
Employees | 4 (4 on RocketReach) |
Founded | 2017 |
Technologies |
JavaScript,
HTML,
PHP
+39 more
(view full list)
|
Industry | Biotechnology, Pharmaceuticals, Executive Office, Design |
Looking for a particular Cadent Therapeutics employee's phone or email?
John McBride is the CFO of Cadent Therapeutics.
4 people are employed at Cadent Therapeutics.
Cadent Therapeutics is based in Cambridge, Massachusetts.